115 related articles for article (PubMed ID: 17598406)
1. Emergence of uropathogenic extended-spectrum beta lactamases-producing Escherichia coli strains in the community.
Marijan T; Vranes J; Bedenić B; Mlinarić-Dzepina A; Plecko V; Kalenić S
Coll Antropol; 2007 Mar; 31(1):227-33. PubMed ID: 17598406
[TBL] [Abstract][Full Text] [Related]
2. Clonal dissemination of highly virulent extended-spectrum beta-lactamase-producing Escherichia coli strains isolated from the urine of non-hospitalised patients in Zagreb region.
Vranes J; Marijan T; Bedenic B; Mlinaric-Dzepina A; Katic S; Kalenic S
Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S19-24. PubMed ID: 17936594
[TBL] [Abstract][Full Text] [Related]
3. Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15.
Yumuk Z; Afacan G; Nicolas-Chanoine MH; Sotto A; Lavigne JP
J Antimicrob Chemother; 2008 Aug; 62(2):284-8. PubMed ID: 18453527
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and types of extended-spectrum beta-lactamases among urinary Escherichia coli and Klebsiella spp. in New Zealand.
Heffernan HM; Woodhouse RE; Pope CE; Blackmore TK
Int J Antimicrob Agents; 2009 Dec; 34(6):544-9. PubMed ID: 19748232
[TBL] [Abstract][Full Text] [Related]
5. Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams.
Kariuki S; Revathi G; Corkill J; Kiiru J; Mwituria J; Mirza N; Hart CA
J Infect Dev Ctries; 2007 Dec; 1(3):257-62. PubMed ID: 19734602
[TBL] [Abstract][Full Text] [Related]
6. CTX-M-1-related extended-spectrum beta-lactamases producing Escherichia coli: so far a sporadic event in Western Austria.
Prelog M; Fille M; Prodinger W; Grif K; Brunner A; Würzner R; Zimmerhackl LB
Infection; 2008 Aug; 36(4):362-7. PubMed ID: 18574554
[TBL] [Abstract][Full Text] [Related]
7. Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting.
Arpin C; Quentin C; Grobost F; Cambau E; Robert J; Dubois V; Coulange L; André C;
J Antimicrob Chemother; 2009 Jun; 63(6):1205-14. PubMed ID: 19329798
[TBL] [Abstract][Full Text] [Related]
8. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Rodríguez-Baño J; Alcalá JC; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
Arch Intern Med; 2008 Sep; 168(17):1897-902. PubMed ID: 18809817
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of rectal carriage of extended-spectrum beta-lactamase-producing Escherichia coli among elderly people in community settings in China.
Tian SF; Chen BY; Chu YZ; Wang S
Can J Microbiol; 2008 Sep; 54(9):781-5. PubMed ID: 18772941
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial resistance, genotypic characterization and pulsed-field gel electrophoresis typing of extended spectrum β-lactamases-producing clinical Escherichia coli strains in Macao, China.
Ye QH; Lau Y; Liang B; Tian SF
Chin Med J (Engl); 2011 Sep; 124(17):2701-7. PubMed ID: 22040428
[TBL] [Abstract][Full Text] [Related]
11. Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology.
Rodríguez-Baño J; López-Cerero L; Navarro MD; Díaz de Alba P; Pascual A
J Antimicrob Chemother; 2008 Nov; 62(5):1142-9. PubMed ID: 18641033
[TBL] [Abstract][Full Text] [Related]
12. [Genotype distribution of extended-spectrum beta-lactamases and AmpC beta-lactamases produced in Escherichia coli isolated from men with urinary infection].
Wang WP; Shao HF; Wang JN; Zhang XW; Shi LN
Zhonghua Nan Ke Xue; 2006 Nov; 12(11):1000-3. PubMed ID: 17146926
[TBL] [Abstract][Full Text] [Related]
13. Extended spectrum beta-lactamases in enteric gram-negative bacilli: related to age and gender.
Mumtaz S; Ahmad M; Aftab I; Akhtar N; ul Hassan M; Hamid A
J Ayub Med Coll Abbottabad; 2007; 19(4):107-11. PubMed ID: 18693612
[TBL] [Abstract][Full Text] [Related]
14. [Detection of novel nucleotide substitutions resulting amino acid substitutions in TEM type beta-lactamase gene isolated from a clinically isolated extended spectrum beta-lactamases (ESBLs) productive Escherichia coli].
Yasuhara T; Fukuchi K; Takagi Y; Gomi K
Rinsho Byori; 2003 Mar; 51(3):201-7. PubMed ID: 12707991
[TBL] [Abstract][Full Text] [Related]
15. Activity of ertapenem and other antimicrobials against ESBL-producing enterobacteria isolated from urine in patients from Madrid.
Tamayo J; Orden B; Cacho J; Cuadros J; Gomez-Garces JL; Alos JI
Rev Esp Quimioter; 2007 Sep; 20(3):334-8. PubMed ID: 18080031
[TBL] [Abstract][Full Text] [Related]
16. Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection.
Rodríguez-Baño J; Alcalá J; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
J Antimicrob Chemother; 2009 Apr; 63(4):781-4. PubMed ID: 19223299
[TBL] [Abstract][Full Text] [Related]
17. [Antibiotic resistance rates of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections in a private hospital].
Akyar I
Mikrobiyol Bul; 2008 Oct; 42(4):713-5. PubMed ID: 19149097
[TBL] [Abstract][Full Text] [Related]
18. Multidrug-resistant Escherichia coli clonal groups causing community-acquired bloodstream infections.
Manges AR; Perdreau-Remington F; Solberg O; Riley LW
J Infect; 2006 Jul; 53(1):25-9. PubMed ID: 16269177
[TBL] [Abstract][Full Text] [Related]
19. The virulence factors and antibiotic sensitivities of Escherichia coli isolated from recurrent urinary tract infections.
Gulsun S; Oguzoglu N; Inan A; Ceran N
Saudi Med J; 2005 Nov; 26(11):1755-8. PubMed ID: 16311661
[TBL] [Abstract][Full Text] [Related]
20. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
Oteo J; Orden B; Bautista V; Cuevas O; Arroyo M; Martínez-Ruiz R; Pérez-Vázquez M; Alcaraz M; García-Cobos S; Campos J
J Antimicrob Chemother; 2009 Oct; 64(4):712-7. PubMed ID: 19671590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
